Vectans Pharma is an international company headquartered in France, dedicated to the optimization of existing treatments and the development of innovative products through its Lauriad® Platform. With a focus on anti-infective drugs and supportive care, Vectans conceives and develops “Best-in-disease” treatments . Created in 2015 , Vectans Pharma’s ambition is to become an healthcare leading player by coupling innovation to patient’s needs. The company’s teams have the key competencies required to identify, develop and register drugs in Europe, Asia, North and South America.